Navigation Links
ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
Date:4/25/2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- One in five patients with stage 3 or 4 chronic obstructive pulmonary disease (COPD) hospitalized for acute exacerbations are readmitted to the hospital within 30 days, but these readmissions may be avoided with the right at-home therapy, according to ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions.

(Photo: http://photos.prnewswire.com/prnh/20130425/LA01492-a)

(Photo  http://photos.prnewswire.com/prnh/20130425/LA01492-b)

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The Food and Drug Administration (FDA) recently cleared ResMed's home variable positive airway pressure (VPAP) device – also known as bilevel PAP – for the treatment of respiratory disorders such as COPD, giving severe COPD sufferers a weapon in the fight to stay out of the hospital. ResMed introduced its VPAP™ COPD device today; it will be sold in the U.S. and because of the FDA's clearance for the treatment of COPD, it will make bilevel therapy more accessible through Medicare's Respiratory Assist Device qualifying guidelines.

"Many stage 3 or stage 4 COPD patients are admitted to the hospital two to three times a year because of their condition, and hospital discharge planners need ways to reduce that figure with better at-home respiratory care," said Geoff Neilson , president of ResMed's Respiratory Care business unit. "Minimizing the likelihood of acute events that lead to readmissions starts at the point of discharge, sending patients home with the best tools like ResMed's VPAP COPD to help them breathe better when their lungs have been damaged by the disease."

The ResMed VPAP COPD is used at night, which helps ensure that COPD patients maintain their ventilation when they are most vulnerable. It customizes the breath delivered to the patient with a rapid inhalation phase and allows an extended exhalation. This can help overcome air trapping that is common in COPD patients, enabling better gas exchange in their lungs.

Built on the popular ResMed S9™ Series platform, the VPAP COPD device is compact and easy for a patient to integrate into a sleep setting. Combined with the companion H5i™ heated humidification device, the VPAP COPD creates a comfortable patient experience, increasing the likelihood of patients continuing their therapy.

ResMed S9 Platform and EasyCare Online Monitoring Provides Total Solution

As part of the total therapy solution, the VPAP COPD device may be wirelessly connected to ResMed's secure, cloud-based EasyCare Online monitoring system. EasyCare Online allows physicians, hospitals and homecare partners to monitor patient use and patient respiratory health on a daily basis. This immediate and automated feedback is critical during the important 30-day post-discharge period, and can help reduce the time and labor hospitals invest in follow-up with these patients, while possibly achieving a better outcome.

ClimateLineMAX™ Oxy Tubing Seamlessly Integrates with Oxygen Therapy

ResMed has also created a special ClimateLine™ tubing between the humidifier and mask that has an oxygen line port next to the VPAP COPD device. Oxygen therapy can be easily combined with the VPAP COPD and its Climate Control humidification system.

"ClimateLineMAX Oxy gives patients a no-compromise solution with the best bilevel therapy and best humidification, with no condensation, and it connects quickly and easily to their source of oxygen," said Neilson. "ResMed takes advantage of each building block for a positive patient experience, from superior comfort to an attractive and easy-to-use device."

The ResMed VPAP COPD and ClimateLineMAX Oxy tubing with oxygen line input are both available now from ResMed authorized dealers.

About ResMed:
ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.


'/>"/>
SOURCE ResMed
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
2. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
3. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
4. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
5. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
8. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
9. ResMed Takes Action to Enforce Patents
10. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
11. Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with Acquisition of PHASEIN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2020)... DETROIT (PRWEB) , ... May 23, 2020 , ... Federal ... United States are African American. However, many news reports are failing to report that ... fact, some were denied a test multiple times. , A new song by an ...
(Date:5/25/2020)... ... , ... AltMed Florida , one of the fastest growing MMTCs in ... Day Opening, starting Monday May 25 for its newest MÜV™ Medical Cannabis Dispensary at ... for crowd mitigation, all licensed Florida medical cannabis patients will receive a one-time use ...
(Date:5/21/2020)... ... May 21, 2020 , ... Rapid ... mid-March 2020 to deliver thousands of critical Personal Protection Equipment (PPE) devices to ... usual aerospace production work, the three companies teamed together to start production of ...
Breaking Medicine Technology:
(Date:5/26/2020)... LOS ANGELES (PRWEB) , ... May 26, 2020 , ... ... speaker, and ageless sexuality advocate Joan Price have just received the 2020 AASECT Audio ... explicit sex education film was the first of its kind to feature non-actors in ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... device manufacturer, announces its first milestone to deliver over one million FDA-compliant face ... weeks. Summit Medical Face Shields meet the critical need for personal protective equipment ...
(Date:5/21/2020)... TROY, Mich. (PRWEB) , ... May 21, 2020 ... ... that the “Stay at Home Order” will be lifted on May 28th and ... a turn-key solution for local companies returning back to work. , As an ...
(Date:5/21/2020)... ... May 21, 2020 , ... JNL Technologies Inc. , ... the release of the SafeHealth screening software. This tool allows companies to ... additional staff or the cost of additional paperwork management. , SafeHealth allows you to ...
(Date:5/16/2020)... ... May 16, 2020 , ... Dr. Tomasz Biernacki states ... prevent permanent arthritis from developing. This can keep the foot from being unable to ... is estimated that the people who develop flat feet and bunion formation ...
Breaking Medicine News(10 mins):